Nisa Investment Advisors LLC Increases Holdings in Cabot Co. (NYSE:CBT)

Nisa Investment Advisors LLC boosted its position in Cabot Co. (NYSE:CBT) by 41.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,777 shares of the specialty chemicals company’s stock after buying an additional 519 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cabot were worth $199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of CBT. BNP Paribas Financial Markets boosted its stake in shares of Cabot by 28.8% in the 1st quarter. BNP Paribas Financial Markets now owns 51,271 shares of the specialty chemicals company’s stock valued at $4,727,000 after purchasing an additional 11,471 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Cabot by 125.4% in the first quarter. Janney Montgomery Scott LLC now owns 10,911 shares of the specialty chemicals company’s stock worth $1,006,000 after purchasing an additional 6,070 shares during the last quarter. Sei Investments Co. boosted its position in Cabot by 6.1% during the first quarter. Sei Investments Co. now owns 862,081 shares of the specialty chemicals company’s stock valued at $79,484,000 after buying an additional 49,467 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Cabot by 571.9% during the second quarter. Assenagon Asset Management S.A. now owns 127,116 shares of the specialty chemicals company’s stock valued at $11,681,000 after buying an additional 108,197 shares during the last quarter. Finally, Tidal Investments LLC increased its holdings in shares of Cabot by 101.7% in the first quarter. Tidal Investments LLC now owns 18,107 shares of the specialty chemicals company’s stock worth $1,669,000 after buying an additional 9,131 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Cabot Trading Up 7.5 %

NYSE CBT opened at $117.02 on Thursday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot Co. has a fifty-two week low of $68.11 and a fifty-two week high of $117.37. The stock has a market cap of $6.42 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The stock has a 50 day simple moving average of $108.41 and a two-hundred day simple moving average of $101.13.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01). The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The business’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.65 EPS. On average, analysts forecast that Cabot Co. will post 7.07 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CBT shares. JPMorgan Chase & Co. raised their price target on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Mizuho raised their target price on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, UBS Group lowered their price target on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus price target of $105.00.

Insider Activity

In related news, EVP Hobart Kalkstein sold 5,457 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the transaction, the executive vice president now directly owns 61,688 shares of the company’s stock, valued at $6,204,579.04. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Cabot news, EVP Hobart Kalkstein sold 5,457 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total transaction of $548,865.06. Following the transaction, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sean D. Keohane sold 25,617 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,665 shares of company stock valued at $4,986,299. Corporate insiders own 3.07% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.